{
    "clinical_study": {
        "@rank": "33623", 
        "arm_group": [
            {
                "arm_group_label": "mesenchymal stem cells", 
                "arm_group_type": "Active Comparator", 
                "description": "Autologous Mesenchymal Stem Cells primed prior to intra articular injection into knees of  patients with advanced articular cartilage injury"
            }, 
            {
                "arm_group_label": "mesenchymal cells&platelet lysate", 
                "arm_group_type": "Active Comparator", 
                "description": "Autologous Mesenchymal Stem Cells primed prior to intra articular injection with platelet lysate into knees of patients with advanced articular cartilage injury"
            }
        ], 
        "brief_summary": {
            "textblock": "Induction of autologous repair chondrogenesis to regenerate injured articular cartilage\n      using bone marrow mesenchymal stem cells (MSCs) after in vitro expansion under restricted\n      culturing conditions."
        }, 
        "brief_title": "Mesenchymal Stem Cells in Knee Cartilage Injuries", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Articular Cartilage Disorder of Knee", 
            "Osteoarthritis, Knee"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cartilage Diseases", 
                "Osteoarthritis", 
                "Osteoarthritis, Knee"
            ]
        }, 
        "detailed_description": {
            "textblock": "Fourteen patients from both genders, age range 40-68, will be enrolled according to strict\n      inclusion and exclusion criteria, divided into two equal groups based upon receiving\n      autologous MSCs alone, or MSCs supported by platelet lysate through percutaneous injection.\n\n      The patients are followed by clinical assessment, laboratory investigations as well as\n      magnetic resonance imaging (MRI) of the injected knee.\n\n      The investigators hypothesize that the two groups will give satisfactory clinical outcomes,\n      but the investigators are looking forward to assessing the best product that will activate\n      chondrogenesis and heal cartilaginous injury."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  MRI must show moderate/severe articular injury\n\n          -  Serum collagen II  must be above the normal value.\n\n          -  Lesion site: Femoral and Tibial condyles or patella\n\n          -  Admission of steroid , NSAID, pain killers must be stopped before 1 month\n\n        Exclusion Criteria:\n\n          -  Lesion size\n\n          -  PT and PTT not within normal value\n\n          -  Complete blood count ( Hb, PCV, and RBC) not within the normal value\n\n          -  HIV and Hepatitis Antigens (B and C) detection"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "68 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02118519", 
            "org_study_id": "KneeUJCTC"
        }, 
        "intervention": {
            "arm_group_label": [
                "mesenchymal stem cells", 
                "mesenchymal cells&platelet lysate"
            ], 
            "description": "Comparison of clinical outcomes of patients injected by mesenchymal  stem cells only with patients injected with mesenchymal  stem cells supported by platelet lysate", 
            "intervention_name": "Autologous Mesenchymal Stem Cells", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Bone marrow derived Mesenchymal Stem Cells", 
            "Knee articular cartilage injury", 
            "Chondrogenesis", 
            "orthopedics"
        ], 
        "lastchanged_date": "April 16, 2014", 
        "location": {
            "contact": {
                "email": "ftmjamali@gmail.com", 
                "last_name": "Fatima Jamali, MSc.", 
                "phone": "009625355000", 
                "phone_ext": "23960"
            }, 
            "contact_backup": {
                "email": "d.hattab@ju.edu.jo", 
                "last_name": "Dana Hattab, MSc.", 
                "phone": "009625355000", 
                "phone_ext": "23960"
            }, 
            "facility": {
                "address": {
                    "city": "Amman", 
                    "country": "Jordan", 
                    "zip": "11942"
                }, 
                "name": "Cell Therapy Center, Jordan University Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Jihad MS AJLOUNI, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Osama A Samara, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Imad Tarawneh, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Jordan"
        }, 
        "number_of_arms": "2", 
        "official_title": "Use of Mesenchymal Stem Cells for the Repair of Articular Cartilage Disorder of Knee Using Intra-articular Injection of Mesenchymal Cells Alone or Mesenchymal Cells With Platelet Lysate", 
        "overall_contact": {
            "email": "ftmjamali@gmail.com", 
            "last_name": "Fatima A Jamali, MSc", 
            "phone": "009625355000", 
            "phone_ext": "23960"
        }, 
        "overall_official": [
            {
                "affiliation": "Cell Therapy Center", 
                "last_name": "Abdallah Awidi, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Jordan University Hospital", 
                "last_name": "Mahasen S Najjar, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Al-Neelain University", 
                "last_name": "Hiba Khalil, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Jordan: Ethical Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Assessing the therapeutic benefits of the injected Autologous Mesenchymal Stem Cells.", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02118519"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Jordan", 
            "investigator_full_name": "Fatima Jamali", 
            "investigator_title": "Researcher", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "For every patient tests would be performed repeated at  6, and 12 months post-injection.", 
            "measure": "Assessment of the articular cartilage healing in osteoarthritic patients through intra articular injection of Autologus Mesenchymal stem cell with/or without supported product.", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "University of Jordan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Jordan", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}